GENNEX LABORATORIES
|
GENNEX LABORATORIES Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹18 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Equity - Authorised | ₹20 Cr | ₹20 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
Equity - Issued | ₹19 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Equity Paid Up | ₹18 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹62 Cr | ₹31 Cr | ₹27 Cr | ₹23 Cr | ₹21 Cr |
Securities Premium | ₹31 Cr | ₹6.00 Cr | ₹6.00 Cr | ₹6.00 Cr | ₹6.00 Cr |
Capital Reserves | ₹0.73 Cr | ₹0.73 Cr | ₹0.73 Cr | ₹0.73 Cr | ₹0.73 Cr |
Profit & Loss Account Balance | ₹30 Cr | ₹24 Cr | ₹20 Cr | ₹16 Cr | ₹14 Cr |
General Reserves | ₹0.72 Cr | ₹0.72 Cr | ₹0.72 Cr | ₹0.72 Cr | ₹0.72 Cr |
Other Reserves | ₹0.06 Cr | ₹-0.12 Cr | ₹-0.12 Cr | ₹-0.12 Cr | ₹-0.12 Cr |
Reserve excluding Revaluation Reserve | ₹62 Cr | ₹31 Cr | ₹27 Cr | ₹23 Cr | ₹21 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹80 Cr | ₹44 Cr | ₹40 Cr | ₹36 Cr | ₹34 Cr |
Minority Interest | ₹6.17 Cr | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹16 Cr | - | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹16 Cr | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹0.53 Cr | - | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-0.14 Cr | ₹0.00 Cr | ₹0.15 Cr | ₹0.40 Cr | ₹0.56 Cr |
Deferred Tax Assets | ₹0.52 Cr | ₹0.51 Cr | ₹0.43 Cr | ₹0.35 Cr | ₹0.27 Cr |
Deferred Tax Liability | ₹0.39 Cr | ₹0.51 Cr | ₹0.58 Cr | ₹0.75 Cr | ₹0.83 Cr |
Other Long Term Liabilities | - | - | ₹0.02 Cr | ₹0.02 Cr | ₹0.06 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | - | - | - | - | - |
Total Non-Current Liabilities | ₹16 Cr | ₹0.00 Cr | ₹0.17 Cr | ₹0.41 Cr | ₹0.62 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹7.08 Cr | ₹7.74 Cr | ₹5.95 Cr | ₹8.13 Cr | ₹8.15 Cr |
Sundry Creditors | ₹7.08 Cr | ₹7.74 Cr | ₹5.95 Cr | ₹8.13 Cr | ₹8.15 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹17 Cr | ₹3.63 Cr | ₹3.29 Cr | ₹5.33 Cr | ₹3.15 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹12 Cr | ₹0.16 Cr | ₹0.37 Cr | ₹1.84 Cr | ₹0.42 Cr |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹5.79 Cr | ₹3.47 Cr | ₹2.92 Cr | ₹3.49 Cr | ₹2.73 Cr |
Short Term Borrowings | ₹1.05 Cr | ₹10 Cr | ₹7.36 Cr | ₹4.98 Cr | ₹4.54 Cr |
Secured ST Loans repayable on Demands | ₹1.05 Cr | ₹10 Cr | ₹7.36 Cr | ₹4.98 Cr | ₹4.54 Cr |
Working Capital Loans- Sec | ₹0.07 Cr | ₹8.48 Cr | ₹2.07 Cr | ₹4.88 Cr | ₹0.09 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-0.07 Cr | ₹-8.48 Cr | ₹-2.07 Cr | ₹-4.88 Cr | ₹-0.09 Cr |
Short Term Provisions | ₹3.99 Cr | ₹2.71 Cr | ₹2.43 Cr | ₹2.42 Cr | ₹1.46 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹3.38 Cr | ₹2.08 Cr | ₹1.87 Cr | ₹2.14 Cr | ₹1.29 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.61 Cr | ₹0.63 Cr | ₹0.56 Cr | ₹0.28 Cr | ₹0.17 Cr |
Total Current Liabilities | ₹30 Cr | ₹24 Cr | ₹19 Cr | ₹21 Cr | ₹17 Cr |
Total Liabilities | ₹132 Cr | ₹68 Cr | ₹59 Cr | ₹57 Cr | ₹52 Cr |
ASSETS | |||||
Gross Block | ₹91 Cr | ₹31 Cr | ₹30 Cr | ₹30 Cr | ₹30 Cr |
Less: Accumulated Depreciation | ₹18 Cr | ₹17 Cr | ₹16 Cr | ₹15 Cr | ₹14 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹74 Cr | ₹14 Cr | ₹14 Cr | ₹15 Cr | ₹16 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹0.02 Cr | - | - | - | - |
Non Current Investments | ₹0.01 Cr | ₹6.83 Cr | ₹6.83 Cr | ₹6.83 Cr | ₹6.83 Cr |
Long Term Investment | ₹0.01 Cr | ₹6.83 Cr | ₹6.83 Cr | ₹6.83 Cr | ₹6.83 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹0.01 Cr | ₹6.83 Cr | ₹6.83 Cr | ₹6.83 Cr | ₹6.83 Cr |
Long Term Loans & Advances | ₹1.35 Cr | ₹0.89 Cr | ₹1.57 Cr | ₹0.22 Cr | ₹0.22 Cr |
Other Non Current Assets | - | - | - | - | - |
Total Non-Current Assets | ₹75 Cr | ₹21 Cr | ₹23 Cr | ₹22 Cr | ₹23 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹16 Cr | ₹7.74 Cr | ₹5.02 Cr | ₹7.44 Cr | ₹5.33 Cr |
Raw Materials | ₹2.58 Cr | ₹1.96 Cr | ₹1.28 Cr | ₹2.09 Cr | ₹1.53 Cr |
Work-in Progress | ₹5.24 Cr | ₹4.28 Cr | ₹2.46 Cr | ₹1.90 Cr | ₹1.75 Cr |
Finished Goods | ₹7.19 Cr | ₹1.15 Cr | ₹1.07 Cr | ₹3.15 Cr | ₹1.80 Cr |
Packing Materials | ₹0.10 Cr | ₹0.05 Cr | ₹0.11 Cr | ₹0.08 Cr | ₹0.05 Cr |
Stores Ā and Spare | ₹0.57 Cr | ₹0.27 Cr | ₹0.09 Cr | ₹0.17 Cr | ₹0.18 Cr |
Other Inventory | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.05 Cr | ₹0.03 Cr |
Sundry Debtors | ₹8.72 Cr | ₹11 Cr | ₹7.66 Cr | ₹6.28 Cr | ₹10 Cr |
Debtors more than Six months | ₹0.33 Cr | ₹0.94 Cr | - | - | - |
Debtors Others | ₹8.39 Cr | ₹9.81 Cr | ₹7.66 Cr | ₹6.28 Cr | ₹10 Cr |
Cash and Bank | ₹15 Cr | ₹8.31 Cr | ₹1.07 Cr | ₹0.91 Cr | ₹3.15 Cr |
Cash in hand | ₹0.56 Cr | ₹0.32 Cr | ₹0.19 Cr | ₹0.19 Cr | ₹0.20 Cr |
Balances at Bank | ₹15 Cr | ₹7.99 Cr | ₹0.88 Cr | ₹0.65 Cr | ₹2.95 Cr |
Other cash and bank balances | - | - | - | ₹0.07 Cr | - |
Other Current Assets | ₹1.18 Cr | ₹0.91 Cr | ₹1.16 Cr | ₹2.06 Cr | ₹2.50 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | ₹0.02 Cr | ₹0.03 Cr | ₹0.07 Cr | ₹0.03 Cr | ₹0.03 Cr |
Prepaid Expenses | ₹0.24 Cr | ₹0.10 Cr | ₹0.13 Cr | ₹0.08 Cr | ₹0.15 Cr |
Other current_assets | ₹0.92 Cr | ₹0.78 Cr | ₹0.96 Cr | ₹1.95 Cr | ₹2.32 Cr |
Short Term Loans and Advances | ₹7.30 Cr | ₹19 Cr | ₹21 Cr | ₹18 Cr | ₹7.68 Cr |
Advances recoverable in cash or in kind | ₹4.78 Cr | ₹17 Cr | ₹18 Cr | ₹16 Cr | ₹5.29 Cr |
Advance income tax and TDS | ₹0.02 Cr | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹2.50 Cr | ₹2.14 Cr | ₹3.01 Cr | ₹2.72 Cr | ₹2.39 Cr |
Total Current Assets | ₹48 Cr | ₹47 Cr | ₹36 Cr | ₹35 Cr | ₹29 Cr |
Net Current Assets (Including Current Investments) | ₹18 Cr | ₹22 Cr | ₹17 Cr | ₹14 Cr | ₹12 Cr |
Miscellaneous Expenses not written off | ₹9.12 Cr | - | - | - | - |
Total Assets | ₹132 Cr | ₹68 Cr | ₹59 Cr | ₹57 Cr | ₹52 Cr |
Contingent Liabilities | ₹0.74 Cr | ₹0.74 Cr | ₹1.70 Cr | ₹1.60 Cr | ₹1.57 Cr |
Total Debt | ₹17 Cr | ₹10 Cr | ₹7.36 Cr | ₹4.98 Cr | ₹4.54 Cr |
Book Value | 3.95 | 3.46 | 3.14 | 2.82 | 2.67 |
Adjusted Book Value | 3.95 | 3.30 | 2.99 | 2.69 | 2.55 |
Compare Balance Sheet of peers of GENNEX LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENNEX LABORATORIES | ₹370.3 Cr | -4.8% | -23.3% | 199.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,311.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹108,623.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,134.3 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹97,408.4 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹92,794.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
GENNEX LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENNEX LABORATORIES | -4.8% |
-23.3% |
199.1% |
SENSEX | -2.6% |
-0% |
21% |
You may also like the below Video Courses